메뉴 건너뛰기




Volumn 68, Issue 18, 2011, Pages 1716-1722

Effect of fondaparinux prophylaxis on anti-factor Xa concentrations in patients with morbid obesity

Author keywords

Anticoagulants; Factor Xa; Fondaparinux sodium; Injections; Obesity; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 10A ANTIBODY; CREATININE; FONDAPARINUX; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

EID: 80053091157     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110010     Document Type: Article
Times cited : (10)

References (41)
  • 1
    • 65449173983 scopus 로고    scopus 로고
    • Cardiology patient pages. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism
    • Rathbun S. Cardiology patient pages. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. Circulation. 2009; 119:e480-2.
    • (2009) Circulation , vol.119
    • Rathbun, S.1
  • 2
    • 0348223709 scopus 로고    scopus 로고
    • A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis
    • DOI 10.1016/j.amjcard.2003.09.057
    • Goldhaber SZ, Tapson VF; for the DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound- confirmed deep vein thrombosis. Am J Cardiol. 2004; 93:259-62. (Pubitemid 38058748)
    • (2004) American Journal of Cardiology , vol.93 , Issue.2 , pp. 259-262
    • Goldhaber, S.Z.1    Tapson, V.F.2
  • 3
    • 46049090201 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • DOI 10.1378/chest.08-0656
    • Geerts WH, Bergqvist D, Pineo GF et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133(suppl 6):381S-453S. (Pubitemid 351894916)
    • (2008) Chest , vol.133 , Issue.6 SUPPL. 6
    • Geerts, W.H.1    Bergqvist, D.2    Pineo, G.F.3    Heit, J.A.4    Samama, C.M.5    Lassen, M.R.6    Colwell, C.W.7
  • 4
    • 32844466981 scopus 로고    scopus 로고
    • Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: Randomised placebo controlled trial
    • Cohen AT, Davidson BL, Gallus AS et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006; 332:325-9.
    • (2006) BMJ , vol.332 , pp. 325-329
    • Cohen, A.T.1    Davidson, B.L.2    Gallus, A.S.3
  • 5
    • 0029802696 scopus 로고    scopus 로고
    • A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness
    • Bergmann JF, Neuhart E. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly inpatients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group. Thromb Haemost. 1996; 76:529-34. (Pubitemid 26372006)
    • (1996) Thrombosis and Haemostasis , vol.76 , Issue.4 , pp. 529-534
    • Bergmann, J.-F.1    Neuhart, E.2
  • 6
    • 0034011571 scopus 로고    scopus 로고
    • Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD
    • The Association of Non-University Affiliated Intensive Care Specialist Physicians of France
    • Fraisse F, Holzapfel L, Couland JM et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med. 2000; 161(4, pt. 1):1109-14.
    • (2000) Am J Respir Crit Care Med , vol.161 , Issue.4 PART 1 , pp. 1109-1114
    • Fraisse, F.1    Holzapfel, L.2    Couland, J.M.3
  • 7
    • 0029999825 scopus 로고    scopus 로고
    • Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients
    • Harenberg J, Roebruck P, Heene DL. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group. Haemostasis. 1996; 26:127-39. (Pubitemid 26173492)
    • (1996) Haemostasis , vol.26 , Issue.3 , pp. 127-139
    • Harenberg, J.1    Roebruck, P.2    Heene, D.L.3
  • 8
    • 0037383972 scopus 로고    scopus 로고
    • Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
    • DOI 10.1067/mhj.2003.189
    • Kleber FX, Witt C, Vogel G et al. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J. 2003; 145:614-21. (Pubitemid 36403489)
    • (2003) American Heart Journal , vol.145 , Issue.4 , pp. 614-621
    • Kleber, F.-X.1    Witt, C.2    Vogel, G.3    Koppenhagen, K.4    Schomaker, U.5    Flosbach, C.W.6
  • 9
    • 9044240038 scopus 로고    scopus 로고
    • The venous thrombotic risk in non-surgical patients: Epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (Enoxaparin)
    • Lechler E, Schramm W, Flosbach CW. The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study Group. Haemostasis. 1996; 26(suppl 2):49-56. (Pubitemid 26098865)
    • (1996) Haemostasis , vol.26 , Issue.SUPPL. 2 , pp. 49-56
    • Lechler, E.1    Schramm, W.2    Flosbach, C.W.3
  • 10
    • 4143085802 scopus 로고    scopus 로고
    • Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
    • DOI 10.1161/01.CIR.0000138928.83266.24
    • Leizorovicz A, Cohen AT, Turpie AG et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004; 110:874-9. (Pubitemid 39096017)
    • (2004) Circulation , vol.110 , Issue.7 , pp. 874-879
    • Leizorovicz, A.1    Cohen, A.T.2    Turpie, A.G.G.3    Olsson, C.-G.4    Vaitkus, P.T.5    Goldhaber, S.Z.6
  • 11
    • 0035668874 scopus 로고    scopus 로고
    • Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
    • DOI 10.1046/j.0007-1323.2001.01800.x
    • Mismetti P, Laporte S, Darmon JY et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001; 88:913-30. (Pubitemid 34015572)
    • (2001) British Journal of Surgery , vol.88 , Issue.7 , pp. 913-930
    • Mismetti, P.1    Laporte, S.2    Darmon, J.-Y.3    Buchmuller, A.4    Decousus, H.5
  • 13
    • 0037048227 scopus 로고    scopus 로고
    • Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: A metaanalysis of 4 randomized double-blind studies
    • Turpie AG, Bauer KA, Eriksson BI et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a metaanalysis of 4 randomized double-blind studies. Arch Intern Med. 2002; 162:1833-40.
    • (2002) Arch Intern Med , vol.162 , pp. 1833-1840
    • Turpie, A.G.1    Bauer, K.A.2    Eriksson, B.I.3
  • 14
    • 34548062022 scopus 로고    scopus 로고
    • Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: A randomized, double-blind comparison
    • DOI 10.1111/j.1538-7836.2007.02657.x
    • Turpie AG, Bauer KA, Caprini JA et al. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007; 5:1854-61. (Pubitemid 47288942)
    • (2007) Journal of Thrombosis and Haemostasis , vol.5 , Issue.9 , pp. 1854-1861
    • Turpie, A.G.G.1    Bauer, K.A.2    Caprini, J.A.3    Comp, P.C.4    Gent, M.5    Muntz, J.E.6
  • 15
    • 26944465426 scopus 로고    scopus 로고
    • Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery
    • DOI 10.1002/bjs.5154
    • Agnelli G, Bergqvist D, Cohen AT et al.; for the PEGASUS investigators. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg. 2005; 92:1212-20. (Pubitemid 41475229)
    • (2005) British Journal of Surgery , vol.92 , Issue.10 , pp. 1212-1220
    • Agnelli, G.1    Bergqvist, D.2    Cohen, A.T.3    Callus, A.S.4    Gent, M.5
  • 16
    • 37449006735 scopus 로고    scopus 로고
    • Meta-analysis of venous thromboembolism prophylaxis in medically ill patients
    • Kanaan AO, Silva MA, Donovan JL et al. Meta-analysis of venous thromboembolism prophylaxis in medically ill patients. Clin Ther. 2007; 29:2395-405.
    • (2007) Clin Ther , vol.29 , pp. 2395-2405
    • Kanaan, A.O.1    Silva, M.A.2    Donovan, J.L.3
  • 17
    • 0037182012 scopus 로고    scopus 로고
    • Cardiovascular risk factors and venous thromboembolism incidence: The longitudinal investigation of thromboembolism etiology
    • Tsai AW, Cushman M, Rosamond WD et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002; 162:1182-9. (Pubitemid 34522408)
    • (2002) Archives of Internal Medicine , vol.162 , Issue.10 , pp. 1182-1189
    • Tsai, A.W.1    Cushman, M.2    Rosamond, W.D.3    Heckbert, S.R.4    Polak, J.F.5    Folsom, A.R.6
  • 18
    • 24744470476 scopus 로고    scopus 로고
    • Obesity as a risk factor in venous thromboembolism
    • DOI 10.1016/j.amjmed.2005.03.012, PII S000293430500207X
    • Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005; 118:978-80. (Pubitemid 41297761)
    • (2005) American Journal of Medicine , vol.118 , Issue.9 , pp. 978-980
    • Stein, P.D.1    Beemath, A.2    Olson, R.E.3
  • 19
    • 0006326387 scopus 로고
    • Relation between weight, obesity, and frequency of deep vein thrombosis after enoxaparin in orthopedic surgery
    • Abstract
    • Samama MM, Verhille C, Darchy L. Relation between weight, obesity, and frequency of deep vein thrombosis after enoxaparin in orthopedic surgery. Thromb Haemost. 1995; 73:977. Abstract.
    • (1995) Thromb Haemost , vol.73 , pp. 977
    • Samama, M.M.1    Verhille, C.2    Darchy, L.3
  • 20
    • 0034649714 scopus 로고    scopus 로고
    • Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty
    • White RH, Gettner S, Newman JM et al. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000; 343:1758-64.
    • (2000) N Engl J Med , vol.343 , pp. 1758-1764
    • White, R.H.1    Gettner, S.2    Newman, J.M.3
  • 21
    • 13444260766 scopus 로고    scopus 로고
    • Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: A subgroup analysis of the PREVENT trial
    • DOI 10.1001/archinte.165.3.341
    • Kucher N, Leizorovicz A, Vaitkus PT et al. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial. Arch Intern Med. 2005; 165:341-5. (Pubitemid 40216291)
    • (2005) Archives of Internal Medicine , vol.165 , Issue.3 , pp. 341-345
    • Kucher, N.1    Leizorovicz, A.2    Vaitkus, P.T.3    Cohen, A.T.4    Turpie, A.G.G.5    Olsson, C.-G.6    Goldhaber, S.Z.7
  • 22
    • 0026643411 scopus 로고
    • Emergency reversal of anticoagulation after intracerebral hemorrhage
    • Fredriksson K, Norrving B, Strömblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke. 1992; 23:972-7.
    • (1992) Stroke , vol.23 , pp. 972-977
    • Fredriksson, K.1    Norrving, B.2    Strömblad, L.G.3
  • 24
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31-41.
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 27
    • 0036174636 scopus 로고    scopus 로고
    • A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery
    • DOI 10.1381/096089202321144522
    • Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002; 12:19-24. (Pubitemid 34155256)
    • (2002) Obesity Surgery , vol.12 , Issue.1 , pp. 19-24
    • Scholten, D.J.1    Hoedema, R.M.2    Scholten, S.E.3
  • 28
    • 77953291437 scopus 로고    scopus 로고
    • Effect of prophylactic dalteparin on anti-factor Xa levels in morbidly obese patients after bariatric surgery
    • Simoneau MD, Vachon A, Picard F. Effect of prophylactic dalteparin on anti-factor Xa levels in morbidly obese patients after bariatric surgery. Obes Surg. 2010; 20:487-91.
    • (2010) Obes Surg , vol.20 , pp. 487-491
    • Simoneau, M.D.1    Vachon, A.2    Picard, F.3
  • 29
    • 54049117972 scopus 로고    scopus 로고
    • Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery
    • Simone EP, Madan AK, Tichansky DS et al. Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery. Surg Endosc. 2008; 22:2392-5.
    • (2008) Surg Endosc , vol.22 , pp. 2392-2395
    • Simone, E.P.1    Madan, A.K.2    Tichansky, D.S.3
  • 30
    • 76949088444 scopus 로고    scopus 로고
    • Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-ill patients
    • Rondina MT, Wheeler M, Rodgers GM et al. Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-ill patients. Thromb Res. 2010; 125:220-3.
    • (2010) Thromb Res , vol.125 , pp. 220-223
    • Rondina, M.T.1    Wheeler, M.2    Rodgers, G.M.3
  • 32
    • 45949086068 scopus 로고    scopus 로고
    • Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • DOI 10.1378/chest.08-0689
    • Hirsh J, Bauer KA, Donati MB et al. Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133(suppl 6):141S-159S. [Erratum, Chest. 2008; 134:473.] (Pubitemid 351892966)
    • (2008) Chest , vol.133 , Issue.6 SUPPL. 6
    • Hirsh, J.1    Bauer, K.A.2    Donati, M.B.3    Gould, M.4    Samama, M.M.5    Weitz, J.I.6
  • 33
    • 0035142879 scopus 로고    scopus 로고
    • Dosing and monitoring of low-molecular-weight heparins in special populations
    • DOI 10.1592/phco.21.2.218.34112
    • Duplaga BA, Rivers CW, Nutescu E. Dosing and monitoring of low-molecularweight heparins in special populations. Pharmacotherapy. 2001; 21:218-34. (Pubitemid 32119200)
    • (2001) Pharmacotherapy , vol.21 , Issue.2 , pp. 218-234
    • Duplaga, B.A.1    Rivers, C.W.2    Nutescu, E.3
  • 34
    • 67449108136 scopus 로고    scopus 로고
    • Low-molecular-weight heparins in renal impairment and obesity: Available evidence and clinical practice recommendations across medical and surgical settings
    • Nutescu EA, Spinler SA, Wittkowsky A et al. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Ann Pharmacother. 2009; 43:1064-83.
    • (2009) Ann Pharmacother , vol.43 , pp. 1064-1083
    • Nutescu, E.A.1    Spinler, S.A.2    Wittkowsky, A.3
  • 35
    • 0036835869 scopus 로고    scopus 로고
    • Use of selective factor Xa inhibitors in special populations
    • Turpie AG. Use of selective factor Xa inhibitors in special populations. Am J Orthop (Belle Mead NJ). 2002; 31(suppl 11):11-5.
    • (2002) Am J Orthop (Belle Mead NJ) , vol.31 , Issue.SUPPL. 11 , pp. 11-15
    • Turpie, A.G.1
  • 36
    • 0035522304 scopus 로고    scopus 로고
    • Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery
    • for the Steering Committee of the Pentasaccharide in Major Knee Surgery Study
    • Bauer KA, Eriksson BI, Lassen MR et al.; for the Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001; 345:1305-10.
    • (2001) N Engl J Med , vol.345 , pp. 1305-1310
    • Bauer, K.A.1    Eriksson, B.I.2    Lassen, M.R.3
  • 37
    • 0035522302 scopus 로고    scopus 로고
    • Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery
    • for the Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study
    • Eriksson BI, Bauer KA, Lassen MR et al.; for the Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001; 345:1298-304.
    • (2001) N Engl J Med , vol.345 , pp. 1298-1304
    • Eriksson, B.I.1    Bauer, K.A.2    Lassen, M.R.3
  • 38
    • 0037129720 scopus 로고    scopus 로고
    • Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: A randomised double-blind trial
    • DOI 10.1016/S0140-6736(02)08648-8
    • Turpie AG, Bauer KA, Eriksson BI et al., for the PENTATHALON 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hipreplacement surgery: a randomised double-blind trial. Lancet. 2002; 359:1721-6. [Erratum, Lancet. 2002; 360:1102.] (Pubitemid 34607085)
    • (2002) Lancet , vol.359 , Issue.9319 , pp. 1721-1726
    • Turpie, A.G.G.1    Bauer, K.A.2    Eriksson, B.I.3    Lassen, M.R.4
  • 39
    • 0037129742 scopus 로고    scopus 로고
    • Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: A randomised double-blind comparison
    • DOI 10.1016/S0140-6736(02)08652-X
    • Lassen MR, Bauer KA, Eriksson BI et al.; for the European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet. 2002; 359:1715-20. (Pubitemid 34607083)
    • (2002) Lancet , vol.359 , Issue.9319 , pp. 1715-1720
    • Lassen, M.R.1    Bauer, K.A.2    Eriksson, B.I.3    Turpie, A.G.G.4
  • 41
    • 0038630900 scopus 로고    scopus 로고
    • Enoxaparin effect depends on bodyweight and current doses may be inadequate in obese patients
    • Frederiksen SG, Hedenbro JL, Norgren L. Enoxaparin effect depends on bodyweight and current doses may be inadequate in obese patients. Br J Surg. 2003; 90:547-8.
    • (2003) Br J Surg , vol.90 , pp. 547-548
    • Frederiksen, S.G.1    Hedenbro, J.L.2    Norgren, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.